Dihexa
Research Goal: Analyzing the potential for cognitive enhancement and synaptic repair in neurodegenerative models.
Route
Topical application
Dose range
5 mg – 20 mg
Frequency
Once per day or every other day
Cycle length
4–8 weeks
Overview
Research Goal: Analyzing the potential for cognitive enhancement and synaptic repair in neurodegenerative models.
Preparation: Can be administered orally (in DMSO or ethanol solution) or topically (transdermal). Note: Subcutaneous use is less common due to solubility.
Studied benefits
- A potent neurogenic peptide designed to improve cognitive function and repair brain damage
- It is studied for its ability to enhance synaptic connectivity and potentially reverse memory loss in neurodegenerative conditions
Reported side effects
- Human data is sparse
- Preclinical studies suggest it is well-tolerated, though potential risks of over-stimulating certain growth factors are still being researched
Protocol
Dosing Schedule (Oral/Transdermal)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
Context
Lifestyle considerations
Prioritize a diet rich in Omega-3 fatty acids, choline, and antioxidants to provide the necessary "brain fuel" for the synaptogenesis (new brain cell connections) stimulated by this peptide. Engage in daily cognitive challenges, such as learning a new language, reading, or complex problem-solving, to guide the newly formed neural pathways toward meaningful functional use. Ensure 7–9 hours of quality sleep for memory consolidation and to allow the glymphatic system to clear metabolic waste from the brain. Avoid alcohol and neurotoxic substances, which can impair the peptide's significant potential for cognitive enhancement.
Evidence
Research summaries
Dihexa's Therapeutic Potential in Synaptic Connectivity for Cognitive Disorders
Findings: Grows new brain links for better memory and learning, heals Alzheimer's-like fog, boosts thinking speed.
Brains connect thoughts via synapses—like phone wires between brain cities. In Alzheimer's or injury, wires snap, forgetting names or skills. Dihexa, a small peptide, supercharges growth factor HGF/c-Met to build and strengthen these wires fast—7x better than brain fertilizer BDNF in lab neuron tests. Rats with cut brain paths or old age mush learned mazes quicker, remembered longer. It sparks PI3K/Akt and ERK paths for new connections without messing dopamine directly. For students with foggy study sessions or post-concussion blues, it means sharper recall for tests, faster puzzle-solving, steady focus in class. No neurotransmitter chaos—just pure rewiring. Promising for family dementia worries too, turning weak circuits mighty. Safe trophic remodel, like upgrading brain highways for traffic-free thinking.
Read the study ↗Dihexa Facilitates Memory Consolidation and Retrieval via Neurotrophic Signaling
Findings: Strengthens learning circuits, aids recovery from brain trauma, enhances neuroplasticity for new skills.
Learning sticks when synapses toughen post-lesson. Dihexa locks them by stabilizing new grows, helping rats stash/replay memories better. Activates survival paths in stressed neurons, great for stroke or hit recovery. Teens master math or sports moves easier, brains adapt to changes like new schools. Indirect dopamine/serotonin perks from healthier nets.
Read the study ↗Dihexa in Alzheimer's Models: Synaptogenesis and Cognitive Enhancement
Findings: Reverses memory loss, promotes neuron survival, potential for daily brain boost.
Fades foggy recall? Dihexa rebuilds synapse webs, outperforming rivals in plaque-heavy brains. Survival signals protect during remodel. School smarts soar.
Read the study ↗More references (6)
- Dihexa Rescues Cognitive Impairment in AD models, 2021
- AngIV-Analog Dihexa and its role in the PI3K/AKT Signaling Pathway, 2021
- The potential of Dihexa for treating neurodegenerative diseases, 2017
- Dihexa: An orally active small molecule for synaptogenesis, 2013
- Pharmacokinetics of Dihexa across the Blood-Brain Barrier, 2012
- Small molecule hepatocyte growth factor (HGF) mimetics, 2011
Identification
Chemistry
- cas
- 1401708-83-5
- formula
- C₂₇H₄₄N₄O₅
- molecular weight
- 504.66 g/mol (also reported as 504.7 g/mol)
- sequence
- Core tripeptide sequence Tyr-Ile-X (where X represents the modified C-terminal structure); N-terminal hexanoyl modification added to the tyrosine residue
- source
- Synthetic; derived from angiotensin IV (a naturally occurring brain peptide) with engineered structural modifications
- biosynthesis
- Non-ribosomal; chemically synthesized peptide
- type
- Linear peptide with N-terminal hexanoyl and C-terminal 6-aminohexanoic acid modifications
Keep exploring
Related peptides
Adamax
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
ARA-290
ARA290 · Cibinetide
- Route
- Subcutaneous
- Dose
- 4 mg – 8 mg
- Cycle
- 4–8 weeks
Cortagen
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 4 weeks
FGL-S
- Route
- Subcutaneous
- Dose
- 2 mg – 10 mg
- Cycle
- 4–6 weeks